Where is the live CopyMark page for USPTO serial 99380465?

The live record is at https://getcopymark.com/trademark/99380465. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns CADENA RESEARCH?

According to the public USPTO record for serial number 99380465, the listed owner(s) include: Centre for Probe Development and Commercialization.

What is USPTO serial number 99380465?

Serial number 99380465 is the USPTO application identifier for the mark CADENA RESEARCH. It is used to track examination, publication, and registration of this trademark.

What is the current status of CADENA RESEARCH?

CADENA RESEARCH (99380465) currently shows USPTO status code 651 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover CADENA RESEARCH?

The public record lists International Classes: 035, 042, 044, 045. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: CADENA RESEARCH Serial# 99380465 | status 651; last event GNS2 | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CADENA RESEARCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Centre for Probe Development and Commercialization
Hamilton, ON, CA
Other trademarks owned by Centre for Probe Development and Commercialization

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian Chau

Brian Chau NORTON ROSE FULBRIGHT CANADA LLP222 Bay Street, Suite 3000Toronto, M5K 1E7CANADA

Goods and services

Class	Description	Status	First use
035	Referrals in the field of testing laboratories for drug development programs; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs	ACTIVE	—
042	Technical consulting in the field of pharmaceutical studies; Consulting services in the field of pharmaceutical research; Pharmaceutical drug development services; Medical and scientific research in the field of radiopharmaceuticals; Scientific research for medical purposes in the field of radiopharmaceuticals; Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research information in the field of radiopharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing information about medical and scientific research; Providing medical research information in the field of pharmaceuticals; Technical writing	ACTIVE	—
044	Medical and pharmaceutical consultation	ACTIVE	—
045	Regulatory compliance consulting in the field of pharmaceuticals	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Sep 24, 2026	GNS2	NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED	—
Sep 24, 2026	GNSI	INQUIRY TO SUSPENSION E-MAILED	—
Sep 24, 2026	CNSI	SUSPENSION INQUIRY WRITTEN	—
Sep 23, 2026	RCCK	SUSPENSION CHECKED - TO ATTORNEY FOR ACTION	—
Mar 26, 2026	GNS3	NOTIFICATION OF LETTER OF SUSPENSION E-MAILED	—
Mar 26, 2026	GNSL	LETTER OF SUSPENSION E-MAILED	—
Mar 26, 2026	CNSL	SUSPENSION LETTER WRITTEN	—
Mar 24, 2026	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Mar 24, 2026	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Mar 24, 2026	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 26, 2026	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2026	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2026	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2026	DOCK	ASSIGNED TO EXAMINER	—
Sep 8, 2025	MAFR	APPLICATION FILING RECEIPT MAILED	—
Sep 8, 2025	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Sep 8, 2025	NWAP	NEW APPLICATION ENTERED	—

CADENA RESEARCH